The FDA approved Ogsiveo (nirogacestat), the first drug indicated for locally aggressive, noncancerous tumors, on Nov. 27.
Read the full post on Becker's Hospital Review - Healthcare News
The FDA approved Ogsiveo (nirogacestat), the first drug indicated for locally aggressive, noncancerous tumors, on Nov. 27.
Read the full post on Becker's Hospital Review - Healthcare News